You know, his folks in the family developed a very interesting technology.

2006 convinced him to go ahead and start scaling it in 2013, or sorry, in 2006, launched the company.

Ended up going public several years later to raise additional capital.

They raised about, they'll call it $100 million total.

Additionally, they've got a Chinese firm that's put in about $12 million, or sorry, $38 million

bucks as an actual customer, basically buying a license for the rights to this pill in China.

The big differentiator, they're able essentially to deliver insulin orally, which goes directly

into the liver versus what we all do today, where I believe what most people do today with diabetes,

which is injections, which goes directly into the bloodstream.

Very different models. We'll see if it takes off.

This is the top entrepreneurs podcast where founders share how they started their

companies and got filthy rich or crash and burn.

Each episode features revenue numbers, customer counts, and other insider information that

creates business news headlines.

We went from a couple of hundred thousand dollars to 2.7 million.

I had no money when I started the company.

It was $160 million, which is the size of any IPOs.

We're a bit strapped.

We have like 22,000 customers.

With over 5 million downloads in a very short amount of time,

major outlets like Inc are calling us the fastest growing business show on iTunes.

I'm your host, Nathan Latka, and here's today's episode.

...